Navigation Links
Radiant Red Fluorescent RNA Stain, 10 ml from Bio-Rad

ProductsRadiant Red Fluorescent RNA Stain, 10 ml from Bio-Rad
Company Bio-Rad
Item Radiant Red Fluorescent RNA Stain, 10 ml
Price 
Description Radiant Red fluorescent RNA stain is used to stain and visualize RNA in denaturing (formaldehyde or glyoxal) agarose gels and does not interfere with northern blotting. Upon excitation with a 302 nm transilluminator, the stain emits a red-orange signal that can be photographed on Polaroid film or with a CCD camera-based gel documentation system. Supplied as 10 ml.
Info Bio-RadBio-Rad
Bio-Rad Laboratories, Inc.
Life Science Research Group
2000 Alfred Nobel Drive
Hercules, CA 94547
USA
Customer Service: 800-424 6723
Fax Number: 800-879 2289
Web Site: http://discover.bio-rad.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Fluorescent Mounting Media from KPL
2. Fluorescent Standards Red Standard from Invitrogen
3. Fluorescent Standards Green Standard from Invitrogen
4. Fluorescent Standards Cyan Standard from Invitrogen
5. Fluorescent Standards Blue Standard from Invitrogen
6. Bio-Beads S-X8 Support, 100 g from Bio-Rad
7. UNOsphere S Support, 100 ml from Bio-Rad
8. Organic Acid Analysis Standard, 6 vials from Bio-Rad
9. Carbohydrate Analysis Standard, 6 vials from Bio-Rad
10. iTaq DNA Polymerase, 250 U from Bio-Rad
11. iTaq DNA Polymerase, 5,000 U from Bio-Rad
15(S)-HETE-d8 is used as an internal standard for the quantification of 15(S)-HETE by stable isotope dilution mass spectrometry....
5(S)-HETE-d8 is used as an internal standard for the quantification of 5(S)-HETE by stable isotope dilution mass spectrometry....
...
Full-length cDNA clone CS0DJ013YG01 of T cells (Jurkat cell line) of Homo sapiens (human). [Source:Uniprot/SPTREMBL;Acc:Q86SZ3] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products:
(Date:4/21/2015)... , April 21, 2015 ... government policies are boosting access control systems market in ... According to a recently published report by TechSci Research ... ", the access control systems market in ... billion by 2020.The access control systems market in the ...
(Date:4/17/2015)... Canada , April 17, 2015 ... growing security concerns, and technological advancement to drive ... until 2020   According ... Saudi Arabia Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric systems ... is projected to register growth at CAGR of ...
(Date:4/13/2015)... 13, 2015 According to ... Biometrics Market Forecast & Opportunities, 2020", the global biometrics ... around 14% till 2020. The biometrics market is ... implementation and review of biometric management systems. The ... products with greater efficiency, are resulting in increasing ...
Breaking Biology News(10 mins):Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
... radioactive "guided missiles," researchers at the Albert Einstein College ... destroyed human immune cells infected with HIV, the virus ... supports the idea that radioimmunotherapy might help in treating ... of the department of microbiology and immunology at Einstein ...
... by Queensland University of Technology is helping scientists better understand ... the development of technology that can speed up the time ... recent graduate Dr Gwynne Hannay has built a gadget capable ... Dr Hannay said his device replicated the mechanical and electrical ...
... California, San Diego have discovered that the presence of a ... (which glow at center due to a fluorescent protein) allows ... its 800 unit eyes, an evolutionary change to an "open ... acuity and angular sensitivity. In contrast, beetles (shown surrounding the ...
Cached Biology News:Einstein researchers demonstrate a novel approach to treating AIDS 2Einstein researchers demonstrate a novel approach to treating AIDS 3Smashing the time it takes to repair our bones 2
(Date:5/21/2015)... 21, 2015  Prima Biomed Ltd. (NASDAQ: PBMD ... to become a leader in the development of immunotherapeutic ... the final CVac data from the Phase II CAN-003 ... for a clinically meaningful improvement in Overall Survival ("OS") ... In the group of second remission patients ...
(Date:5/21/2015)... May 21, 2015  The EveryLife Foundation for ... (R-UT) and Amy Klobuchar (D-MN) today ... Cures & Treatments, or OPEN ACT. ... advocacy organizations, this bipartisan legislation promises to rapidly ... to rare disease patients by incentivizing drug makers ...
(Date:5/21/2015)... May 21, 2015 W. R. ... manufacturing facility in Worms, Germany has received good ... subsidiary of the International Pharmaceutical Excipient Council (IPEC) ... that produce its SYLOID® FP brand of pharmaceutical ... certification, following the Curtis Bay, Maryland (USA) and ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation ... development company specializing in oncology, today announced positive ... trial with aldoxorubicin for the treatment of unresectable ... cancer.  The open-label, multisite trial is designed to ... in patients whose tumors have progressed following prior ...
Breaking Biology Technology:Correction Continues after Big Move - BrokerBank Securities, Inc. 2Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7